This Article  • References  • Full text PDF  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (40)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Thomas C. Quinn, MD; Charles H. Riggin, PhD; Richard L. Kline, MS; Henry Francis, MD; Kabeya Mulanga, MS; Michael G. Sension, MD; Anthony S. Fauci, MD

JAMA. 1988;260(4):510-513.

Abstract
Unscreened blood transfusions continue to be one of the major modes of transmission of the human immunodeficiency virus (HIV) in developing countries, such as in Central Africa, where 5% to 18% of blood donors are HIV seropositive. We evaluated a rapid latex agglutination assay using a novel recombinant envelope polypeptide of HIV for the detection of HIV antibodies among 2820 blood donors and clinical patients from diverse geographic regions, including on-site testing in Central Africa of 1600 blood donors. Overall, 29.2% of the serum samples were positive by Western blot assay. On a single determination, the latex agglutination slide test was found to be highly sensitive and specific compared with Western blot results in these populations with a relatively high prevalence of infection. Use of this assay will allow the immediate implementation of serologic screening for HIV in developing areas of the world, where standard screening procedures are impractical or not available, and in many other clinical settings, such as sexually transmitted diseases clinics and hospitals, where testing and counseling could be promptly implemented.

(JAMA 1988;260:510-513)

Author Affiliations
From the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md (Drs Quinn, Francis, and Fauci); Cambridge Bio-Science Corp, Hopkinton, Mass (Dr Riggin); the Division of Infectious Diseases, The Johns Hopkins University School of Medicine, Baltimore (Drs Quinn and Sension and Mr Kline); and Project SIDA, Kinshasa, Zaire (Drs Francis and Sension and Mrs Mulanga).; Dr Riggin is an employee of Cambridge BioScience Corp. None of the other authors have any financial interest in Cambridge BioScience Corp. This work does not represent any specific endorsement by the US government of a commercial product.

Footnotes
Reprint requests to The Johns Hopkins Hospital, 600 N Wolfe St, Blalock 1111, Baltimore, MD 21205 (Dr Quinn).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

HIV Infection Following Motor Vehicle Trauma in Central Africa
Hill
JAMA 1989;261:3282-3283.
ABSTRACT  

RAPID ASSAY FOR HIV ANTIBODIES FIELD-TESTED IN AFRICA
JWatch General 1988;1988:5-5.
FULL TEXT